Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors

Y Shan, C Wang, L Zhang, J Wang, M Wang… - Bioorganic & Medicinal …, 2016 - Elsevier
Recently approved multi-target inhibitors of receptor tyrosine kinases (RTKs) have
significantly improved the clinical treatment of cancers. A series of N, N′-diarylureas …
被引用次数：22 相关文章

Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors

Y Shan, C Wang, L Zhang, J Wang… - Bioorganic & …, 2016 - pubmed.ncbi.nlm.nih.gov
Recently approved multi-target inhibitors of receptor tyrosine kinases (RTKs) have
significantly improved the clinical treatment of cancers. A series of N, N'-diarylureas …

Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors

Y Shan, C Wang, L Zhang, J Wang, M Wang… - Bioorganic & Medicinal …, 2016 - infona.pl
Recently approved multi-target inhibitors of receptor tyrosine kinases (RTKs) have
significantly improved the clinical treatment of cancers. A series of N, N′-diarylureas …

Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors.

Y Shan, C Wang, L Zhang, J Wang… - … & Medicinal Chemistry, 2015 - europepmc.org
Recently approved multi-target inhibitors of receptor tyrosine kinases (RTKs) have
significantly improved the clinical treatment of cancers. A series of N, N'-diarylureas …

Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors

Y Shan, C Wang, L Zhang, J Wang, M Wang… - Bioorganic & Medicinal …, 2016 - hero.epa.gov
Recently approved multi-target inhibitors of receptor tyrosine kinases (RTKs) have
significantly improved the clinical treatment of cancers. A series of N, N'-diarylureas …